- Report
- March 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- March 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- December 2024
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- September 2024
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,802GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,802GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,802GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,802GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,802GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,802GBP
- Report
- August 2025
- 150 Pages
Global
From €3514EUR$3,950USD£3,035GBP
- Report
- August 2025
- 150 Pages
Global
From €3514EUR$3,950USD£3,035GBP
- Report
- March 2025
- 240 Pages
Global
From €4444EUR$4,995USD£3,837GBP
- Report
- April 2025
- 199 Pages
Global
From €4444EUR$4,995USD£3,837GBP
- Report
- March 2025
- 105 Pages
Global
From €3500EUR$4,214USD£3,128GBP
- Report
- April 2025
- 59 Pages
Global
From €2625EUR$2,950USD£2,266GBP
- Report
- November 2024
- 82 Pages
Global
From €4448EUR$5,000USD£3,841GBP
- Report
- July 2025
- 250 Pages
Global
From €2312EUR$2,599USD£1,997GBP
- Report
- June 2025
- 106 Pages
Global
From €3069EUR$3,450USD£2,650GBP
- Report
- June 2025
- 194 Pages
Global
From €4404EUR$4,950USD£3,803GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more